We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.


New Trading Tool: Live US Options Flow! Try it out.

BATS British American Tobacco Plc

-9.50 (-0.35%)
21 Sep 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Share Name Share Symbol Market Type Share ISIN Share Description
British American Tobacco Plc LSE:BATS London Ordinary Share GB0002875804 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -9.50 -0.35% 2,725.50 2,720.50 2,721.00 2,742.00 2,713.00 2,733.00 2,483,833 16:35:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Cigarettes - - 271.3 40.6 272,539.87

FDA Orders British American Tobacco Unit to Stop Marketing Menthol Vape Cartridges

17/03/2023 4:09pm

Dow Jones News

British American Tobacco (LSE:BATS)
Historical Stock Chart

From Sep 2022 to Sep 2023

Click Here for more British American Tobacco Charts.

By Dean Seal


The U.S. Food and Drug Administration has denied a British American Tobacco PLC unit's marketing applications for two menthol e-cigarette replacement cartridges.

The agency said Friday that it has ordered the R.J. Reynolds Vapor Co. to stop marketing the e-cigarette products, which are sold under the Vuse Solo brand.

R.J. Reynolds Vapor, a subsidiary of British American Tobacco's Reynolds American Inc., submitted premarket applications that "lacked sufficient evidence" showing that marketing the e-cigarette products would be appropriate for the protection of public health, the FDA said.

"Specifically, evidence submitted by the applicant did not demonstrate that its menthol-flavored e-cigarettes provide an added benefit for adult smokers relative to tobacco-flavored e-cigarettes," according to the FDA.

The FDA said menthol-flavored e-cigarettes have a higher risk "with regard to youth appeal, uptake and use" than their tobacco-flavored counterparts. Because of that, applicants have to provide robust evidence that their menthol-flavored vape products do a better job than tobacco-flavored e-cigarettes at promoting a switch from, or reduction in use of, traditional cigarettes in adult smokers, according to the regulator.

Retailers of the unauthorized e-cigarette products should contact R.J. Reynolds Vapor with any questions about products in their inventory, the FDA said.

A spokesman for R.J. Reynolds Vapor didn't immediately respond to a request for comment.


Write to Dean Seal at dean.seal@wsj.com


(END) Dow Jones Newswires

March 17, 2023 11:54 ET (15:54 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

1 Year British American Tobacco Chart

1 Year British American Tobacco Chart

1 Month British American Tobacco Chart

1 Month British American Tobacco Chart
Your Recent History
British Am..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: gb D: 20230921 18:40:35